Methylation patterns of the E-cadherin 5' CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression.
about
Methyl-H3K9-binding protein MPP8 mediates E-cadherin gene silencing and promotes tumour cell motility and invasionGATA3 inhibits breast cancer metastasis through the reversal of epithelial-mesenchymal transitionNuclear speckle-associated protein Pnn/DRS binds to the transcriptional corepressor CtBP and relieves CtBP-mediated repression of the E-cadherin geneThe p120 catenin partner Kaiso is a DNA methylation-dependent transcriptional repressorThe E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression.Epithelial-Mesenchymal Transition and Breast CancerClinicopathological significance and potential drug target of CDH1 in breast cancer: a meta-analysis and literature reviewRole of hypoxia-inducible factors in breast cancer metastasisSheep, wolf, or werewolf: cancer stem cells and the epithelial-to-mesenchymal transitionc-Jun N-Terminal Kinases Mediate a Wide Range of Targets in the Metastatic CascadeImplications of Hypoxia in Breast Cancer Metastasis to BoneE-cadherin mutation and Snail overexpression as alternative mechanisms of E-cadherin inactivation in synovial sarcomaMethylation mattersExpression level and DNA methylation status of glutathione-S-transferase genes in normal murine prostate and TRAMP tumorsDown-regulation of epithelial cadherin is required to initiate metastatic outgrowth of breast cancer.Epigenetic silencing of the adhesion molecule ADAM23 is highly frequent in breast tumors.MeCP2 and promoter methylation cooperatively regulate E-cadherin gene expression in colorectal carcinoma.CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer.Inhibition of SIRT1 reactivates silenced cancer genes without loss of promoter DNA hypermethylation.Dynamics of adipogenic promoter DNA methylation during clonal culture of human adipose stem cells to senescence.DNA hypermethylation and clinicopathological features in breast cancer: the Western New York Exposures and Breast Cancer (WEB) Study.Expression analysis of E-cadherin, Slug and GSK3beta in invasive ductal carcinoma of breast.Promoter methylation of E-cadherin in hepatocellular carcinomas and dysplastic nodulesAllele-specific CDH1 downregulation and hereditary diffuse gastric cancer.Heterogeneity for stem cell-related markers according to tumor subtype and histologic stage in breast cancer.Seed in soil, with an epigenetic viewEpigenetic regulation of epithelial-mesenchymal transitionInvolvement of members of the cadherin superfamily in cancerVariable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment.Investigating stem cells in human colon by using methylation patterns.Local regulation of human breast xenograft models.Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition.Chromatin remodeling in mammary gland differentiation and breast tumorigenesis.E-cadherin as an indicator of mesenchymal to epithelial reverting transitions during the metastatic seeding of disseminated carcinomas.Reduced ING1 levels in breast cancer promotes metastasisThe cadherin-catenin adhesion system in signaling and cancer.TIMP-1 via TWIST1 induces EMT phenotypes in human breast epithelial cellsThe candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma.Heterogeneity in the modification and involvement of chromatin components of the CpG island of the silenced human CDH1 gene in cancer cells.Multilayer control of the EMT master regulators.
P2860
Q24300994-4727E1CE-888D-4DA3-B621-1D5BB8A1401DQ24301339-ABE983C1-6FB0-4190-8771-DC8BF856DBA4Q24559995-475C31D2-C39E-4F20-B596-3CE8C1DA2875Q24601117-B5922960-56E0-4C39-93A5-41BA7C9537C7Q24801633-D7D7E6FA-FBC5-4369-A156-B47F0AAFCB40Q26773055-79832207-03DE-4D38-91E3-66C2C5B6FEC7Q26783596-6D038AFF-336B-47A4-9B5E-992E4E802500Q26860122-CC9B3DB4-C4D6-4551-A428-F28A96DDBD27Q26864979-8D45ABB3-46AF-4382-A0D5-F5B9F2FBEB63Q26998420-B7403AD9-0771-4C49-82C2-1D1EBEF778A4Q28077444-15E1D9D4-5DAA-419A-8391-C66CFCCBA6EDQ28286408-B4C27589-9CF7-48F6-9055-8DE2D4189F92Q28364163-098965A6-433A-405A-9E9A-3133D21F5690Q28748604-1D7C6781-AF0A-463D-9E42-DF0CA34BDC3FQ30502431-BA5AD3D6-221A-40F1-850F-42D2CB151318Q30885681-6FB90736-87BF-4B0C-9E37-19DF6F76AF8AQ30952414-86556198-4E75-4A3F-A168-FF78C27A838CQ33235269-F9CBAB74-1DAE-4CAE-A521-EB6012FD9B1BQ33238940-6B715006-B96A-42B6-8608-CD77F18A3B06Q33286093-7B2350AB-F25E-42B1-90A6-C123914430B0Q33332509-0756A33E-5B4D-4FEF-A88F-439B8E0E037DQ33502878-33752465-49BE-46AC-8C9C-57D1D069D2C7Q33599535-531CA111-3F18-4450-9D9F-E8F9E98D4A0FQ33630653-D2836060-EFD5-40BB-A6A3-C1D12754B4CEQ33638070-98706E4F-C215-4D95-86B8-70C659739DBAQ33754753-7CC6FF41-D542-4541-89DF-1862CF667C5FQ33764436-7727758C-D943-4CF2-AA98-89A042CC8988Q33899441-3F254120-D033-463E-95EC-538F293F6ED3Q33943198-9019B705-281C-4B93-95B3-C6C4A37F359DQ33943888-6C7321B3-50F8-4114-B90E-F85EDDDF5C57Q33964451-F9ACD397-28B8-4467-BC1F-C9F8F919DD49Q34008577-DECAAB65-36AD-4D0E-A596-FE1EACD9125BQ34080232-B8DC73BB-0139-460C-A11B-FF5315E22ED4Q34088774-4B7534FA-84C9-46F5-8801-9B4F9CC3F8F7Q34100927-D78B6302-283C-4E3D-86B0-61A8ADAFD833Q34124023-2E448381-7E9A-4EF7-B593-867DB4A0A612Q34224634-71AECCAD-8632-4CE1-AFF7-DF3D67BEEDCAQ34318060-EF459C6A-B3AA-4BEC-80FB-84E2E9989A4BQ34329052-64AFB183-DF10-4A9E-A196-6178850DDC6EQ34340552-38E9EAB9-D0A4-4778-9600-9BE4B22A8450
P2860
Methylation patterns of the E-cadherin 5' CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Methylation patterns of the E- ...... during metastatic progression.
@ast
Methylation patterns of the E- ...... during metastatic progression.
@en
type
label
Methylation patterns of the E- ...... during metastatic progression.
@ast
Methylation patterns of the E- ...... during metastatic progression.
@en
prefLabel
Methylation patterns of the E- ...... during metastatic progression.
@ast
Methylation patterns of the E- ...... during metastatic progression.
@en
P2093
P2860
P356
P1476
Methylation patterns of the E- ...... during metastatic progression.
@en
P2093
P2860
P304
P356
10.1074/JBC.275.4.2727
P407
P577
2000-01-01T00:00:00Z